Johnny Mahlangu Selected Research

Johnny Mahlangu Research Topics

Disease

45	Hemophilia A (Haemophilia) 04/2024 - 01/2012
24	Hemorrhage 04/2024 - 01/2014
8	Hemophilia B (Haemophilia B) 07/2023 - 12/2014
4	Body Weight (Weight, Body) 08/2023 - 01/2018
3	Pain (Aches) 07/2022 - 04/2017
2	Iron Deficiencies 08/2023 - 01/2020
2	Thrombosis (Thrombus) 05/2023 - 01/2022
2	Hypersensitivity (Allergy) 07/2022 - 11/2021
2	Thrombotic Microangiopathies 01/2021 - 01/2018
1	Chronic Disease (Chronic Diseases) 08/2023
1	Anaphylaxis (Anaphylactic Shock) 02/2022
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 02/2022
1	Hemolysis 02/2022
1	HIV Infections (HIV Infection) 02/2022
1	Infections 01/2022
1	Inflammation (Inflammations) 01/2022
1	Headache (Headaches) 01/2022
1	Acute Pain 01/2022
1	Nausea 01/2022
1	Fatigue 01/2022
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2022
1	Thalassemia 01/2022
1	Surgical Wound 11/2021
1	Myocardial Infarction 01/2021
1	Chronic Renal Insufficiency 01/2020
1	Metrorrhagia (Spotting) 12/2019
1	Familial Multiple Coagulation Factor Deficiency I 06/2008

Drug/Important Bio-Agent (IBA)

17	Factor VIII (Coagulation Factor VIII)IBA 04/2024 - 01/2018
14	emicizumabIBA 02/2024 - 01/2018
7	recombinant FVIIa (rFVIIa)FDA Link 02/2024 - 01/2012
7	Monoclonal AntibodiesIBA 02/2024 - 01/2019
6	AntibodiesIBA 08/2022 - 01/2018
5	Factor IX (Coagulation Factor IX)FDA LinkGeneric 02/2024 - 12/2014
5	factor IX Fc fusion proteinIBA 07/2023 - 01/2017
4	Valoctocogene RoxaparvovecIBA 04/2024 - 01/2022
4	Blood Coagulation Factors (Coagulation Factor)IBA 03/2024 - 07/2021
3	Factor VII (Proconvertin)IBA 07/2022 - 08/2021
3	Hemostatics (Antihemorrhagics)IBA 01/2022 - 01/2014
3	Factor VIIa (Activated Factor VII)IBA 08/2021 - 12/2015
3	nonacog beta pegolIBA 11/2018 - 12/2014
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2020
2	A-factor (Streptomyces)IBA 12/2023 - 01/2022
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 08/2023 - 01/2023
2	AutoantibodiesIBA 01/2023 - 01/2022
2	human F8 protein FDA Link 01/2023 - 06/2020
2	Heme (Haem)IBA 09/2021 - 05/2019
2	Prothrombin (Factor II)IBA 01/2021 - 12/2015
2	factor VIII-Fc fusion proteinIBA 05/2020 - 01/2014
1	Chromogenic CompoundsIBA 04/2024
1	concizumabIBA 08/2023
1	Transferrin Receptors (Transferrin Receptor)IBA 08/2023
1	IronIBA 08/2023
1	Ferritins (Ferritin)IBA 08/2023
1	marstacimabIBA 01/2023
1	B-domain-deleted factor VIIIIBA 01/2023
1	sugar formulated recombinant FVIIIIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	BESIBA 07/2022
1	Immunoglobulins (Immunoglobulin)IBA 02/2022
1	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 02/2022
1	Immunoglobulin G (IgG)IBA 02/2022
1	CytokinesIBA 01/2022
1	canakinumab FDA Link 01/2022
1	InflammasomesIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	marzeptacog alfa (activated)IBA 08/2021
1	HepcidinsIBA 01/2020
1	Growth Differentiation Factor 15IBA 01/2020
1	Factor IXa (Coagulation Factor IXa)IBA 12/2019
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	vatreptacog alfaIBA 01/2012
1	NN1731IBA 01/2012
1	platelet factor VIBA 06/2008

Therapy/Procedure

11	Therapeutics 08/2023 - 01/2018
2	Perioperative Care 11/2021 - 11/2021
1	Immunotherapy 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Operative Surgical Procedures 11/2021
1	Time-to-Treatment 04/2017